Ohio Public Employees Retirement System (OPERS)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.11M | Sell |
|
|||||
|
2025
Q1 | $3.69M | Sell |
|
|||||
|
2024
Q4 | $5.53M | Sell |
|
|||||
|
2024
Q3 | $4.95M | Sell |
|
|||||
|
2024
Q2 | $6.74M | Buy |
|
|||||
|
2024
Q1 | $6.61M | Buy |
|
|||||
|
2023
Q4 | $5.92M | Buy |
|
|||||
|
2023
Q3 | $4.45M | Sell |
|
|||||
|
2023
Q2 | $4.13M | Sell |
|
|||||
|
2023
Q1 | $4.83M | Sell |
|
|||||
|
2022
Q4 | $5.8M | Buy |
|
|||||
|
2022
Q3 | $5.05M | Buy |
|
|||||
|
2022
Q2 | $4.6M | Sell |
|
|||||
|
2022
Q1 | $4.56M | Sell |
|
|||||
|
2021
Q4 | $4.28M | Sell |
|
|||||
|
2021
Q3 | $5.01M | Sell |
|
|||||
|
2021
Q2 | $5.2M | Buy |
|
|||||
|
2021
Q1 | $4.81M | Buy |
|
|||||
|
2020
Q4 | $4.33M | Buy |
|
|||||
|
2020
Q3 | $3.51M | Buy |
|
|||||
|
2020
Q2 | $4.28M | Sell |
|
|||||
|
2020
Q1 | $3.07M | Buy |
|
|||||
|
2019
Q4 | $3.31M | Sell |
|
|||||
|
2019
Q3 | $4.48M | Buy |
|
|||||
|
2019
Q2 | $4.19M | Sell |
|
|||||
|
2019
Q1 | $4.48M | Buy |
|
|||||
|
2018
Q4 | $3.33M | Sell |
|
|||||
|
2018
Q3 | $6.15M | Sell |
|
|||||
|
2018
Q2 | $5.05M | Sell |
|
|||||
|
2018
Q1 | $4.29M | Buy |
|
|||||
|
2017
Q4 | $2.9M | Buy |
|
|||||
|
2017
Q3 | $2.18M | Sell |
|
|||||
|
2017
Q2 | $1.69M | Sell |
|
|||||
|
2017
Q1 | $1.61M | Hold |
|
|||||
|
2016
Q4 | $1.58M | Sell |
|
|||||
|
2016
Q3 | $3.52M | Buy |
|
|||||
|
2016
Q2 | $2.52M | Buy |
|